• Galecto Inc GLTO.OQ reported a quarterly adjusted loss of $5.23​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $-6.00. The mean expectation of two analysts for the quarter was for a loss of $2.97 per share. Wall Street expected results to range from $-3.12 to $-2.82 per share.

• Reported revenue was zero​; analysts expected zero.

• Galecto Inc's reported EPS for the quarter was a loss of $5.23​.

• The company reported a quarterly loss of $6.74 million.

• Galecto Inc shares had fallen by 7.7% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 12.9% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for Galecto Inc is $8.00

This summary was machine generated from LSEG data March 19 at 09:11 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)